Huete, Lanz Asher A.
HRN: 21-11-69 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/27/2022
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
05/27/2022
06/02/2022
IV
1000mg
Q6h
PCAP C
Waiting Final Action
Indication: Type of Infection: Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes